BAFNAPH — BAFNA Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Annual balance sheet for BAFNA Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	R2022 March 31st	2023 March 31st	C2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	—	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	1.73	78.1	14	34.3	20.2
Net Total Accounts Receivable
Net Total Receivables	155	559	615	521	552
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	509	873	938	847	897
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	388	402	507	661	849
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	901	1,296	1,477	1,531	1,755
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	220	465	541	519	572
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	282	561	668	683	794
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	620	735	808	848	961
Total Liabilities & Shareholders' Equity	901	1,296	1,477	1,531	1,755
Total Common Shares Outstanding